Do FADS1 and FADS2 variants affect conversion of fatty-acid precursors into EPA?

Endogenous synthesis of long-chain polyunsaturated fatty acids (LC-PUFAs) is highly dependent on individual genetic architecture, specifically within the fatty acid desaturase (FADS) gene cluster.

Genetic and enzymatic mechanisms

• Polymorphisms in the FADS1 (such as rs174547) and FADS2 (such as rs1535) genes directly alter the expression and activity of delta-5 desaturase (D5D) and delta-6 desaturase (D6D) enzymes.
• Minor-allele carriers of these single nucleotide polymorphisms (SNPs) experience a significant metabolic constraint, demonstrating a lower rate-limiting conversion of dietary alpha-linolenic acid (ALA) precursors into eicosapentaenoic acid (EPA).
• Stable isotope tracer studies confirm that minor-allele homozygotes exhibit diminished plasma EPA enrichment and lower circulating EPA/ALA ratios following precursor ingestion compared to major-allele "high-converter" genotypes.

Dietary competition and metabolic bottlenecks

• The D5D and D6D enzymes are shared pathways for both omega-3 and omega-6 fatty acid metabolism.
• High dietary intake of linoleic acid (LA, n-6) directly competes with ALA (n-3) for desaturase enzyme binding, further suppressing the endogenous synthesis of EPA in individuals who already carry low-activity FADS variants.

Bypassing genetic limitations

• Direct consumption of preformed EPA and DHA from marine or algal sources completely bypasses these endogenous enzymatic desaturation bottlenecks, successfully elevating systemic LC-PUFA status regardless of genetic predisposition.

Bottom line

• Bottom line: Variants in FADS1 and FADS2 introduce substantial individual variability in the conversion of ALA to EPA. Because high dietary omega-6 intake exacerbates this bottleneck through enzyme competition, individuals with low-activity variants require direct supplementation with preformed marine or algal EPA and DHA to reliably achieve optimal LC-PUFA status.